review on 2016 fda approvals, halt on aml trials, and more
Published 7 years ago • 82 plays • Length 7:11
Download video MP4
Download video MP3
Similar videos
-
8:45
fda approvals in gvhd, crc, and aml, a priority review in mcl, and more
-
8:48
fda approval in aml, priority review designation in nsclc, and more
-
10:35
fda approval in aml, nda submitted in myeloma, clinical hold on car t-cell therapy trials, and more
-
8:51
fda approvals in nets, breast cancer, aml, a biosimilar, and more
-
10:18
fda approvals in bladder cancer and hodgkin lymphoma, breakthrough designation in aml, and more
-
20:59
the blessing and curse of direct oral anticoagulants in the bleeding patient
-
15:12
multiple myeloma: diagnosis, prevention, and treatment
-
18:34
let's talk epithelioid sarcoma with seth m. pollack, md
-
9:10
fda approvals in cml and hodgkin lymphoma, priority review in crc, and more
-
8:51
fda approvals in prostate cancer and nsclc, priority review in aml, odac in all, and more
-
9:29
fda approvals in all and breast cancer, priority reviews in cml and follicular lymphoma, and more
-
10:01
fda approvals in sclc and a biosimilar, and japanese approvals in aml, ntrk tumors, and more
-
7:28
fda approvals in pml, nsclc, and breast cancer, priority review in dlbcl, and more
-
9:54
fda approval in nsclc, priority review designation in sclc, crl to biosimilar, and more
-
10:46
fda approval in all, priority reviews in cml and breast cancer, and more
-
2:26
overview of 4 fda approvals in acute myeloid leukemia
-
7:21
fda approval in breast cancer, breakthrough designations in aml and bladder cancer, and more
-
8:22
regulatory update: three fda approvals and two priority reviews
-
9:02
fda approval in sarcoma, priority reviews in mcrpc and myeloma, and more
-
5:21
fda approvals in cll and all, nda accepted in melanoma, and more
-
4:26
fda approvals in 2015: year in review
-
7:39
fda approvals in all, ovarian cancer, priority review in ctcl, and snda submitted in rcc
Clip.africa.com - Privacy-policy